model,flat_path,key_cat,val_cat,ref_val,pred_val,val_match,sim,score_status,piece,norm_path,from_pred,in_ref,in_pred,type_mismatch,is_enum,sim_failed
Claude-4.5-Sonnet,protocolSection.identificationModule.nctId,TP,TP,NCT04084392,NCT04084392,True,1.0,exact,NCTId,protocolSection.identificationModule.nctId,False,True,True,False,False,False
Claude-4.5-Sonnet,protocolSection.identificationModule.secondaryIdInfos[0].id,EV,EV,,UL1 TR002243,,,,SecondaryId,protocolSection.identificationModule.secondaryIdInfos.id,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.identificationModule.secondaryIdInfos[0].type,EV,EV,,NIH,,,,SecondaryIdType,protocolSection.identificationModule.secondaryIdInfos.type,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.identificationModule.secondaryIdInfos[0].domain,EV,EV,,National Center for Advancing Translational Sciences,,,,SecondaryIdDomain,protocolSection.identificationModule.secondaryIdInfos.domain,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.identificationModule.briefTitle,TP,TP,Evaluating the Impact of the Bridge Clinic in Patients With Opioid Use Disorder,Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE) trial,True,0.86,success,BriefTitle,protocolSection.identificationModule.briefTitle,False,True,True,False,False,False
Claude-4.5-Sonnet,protocolSection.identificationModule.officialTitle,TP,TP,Evaluating the Impact of the Bridge Clinic in Patients With Opioid Use Disorder,"Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE) trial: a pragmatic, randomized controlled trial of a transitional bridge clinic intervention for hospitalized patients with opioid use disorder",True,0.94,success,OfficialTitle,protocolSection.identificationModule.officialTitle,False,True,True,False,False,False
Claude-4.5-Sonnet,protocolSection.identificationModule.acronym,EV,EV,,BRIDGE,,,,Acronym,protocolSection.identificationModule.acronym,True,False,True,False,False,False
Claude-4.5-Sonnet,protocolSection.descriptionModule.briefSummary,TP,TP,This study aims to determine whether referral to the Bridge Clinic reduces overall index hospital length of stay when compared to direct referral to a long-term outpatient addiction provider for patients with active opioid use disorder (OUD) being considered for medications-for-addiction treatment (MAT).,"This study evaluates whether a transitional bridge clinic improves outcomes for hospitalized patients with opioid use disorder (OUD) who are starting medication for OUD (MOUD). Patients are randomly assigned to either receive referral to a co-located, multidisciplinary bridge clinic or to usual care with community referrals. The primary outcome is hospital length of stay. Secondary outcomes include quality of life, linkage to ongoing care, medication fills, relapse rates, readmission rates, and costs of care.",True,0.93,success,BriefSummary,protocolSection.descriptionModule.briefSummary,False,True,True,False,False,False
Claude-4.5-Sonnet,protocolSection.descriptionModule.detailedDescription,EV,EV,,"The BRIDGE (Bridging Recovery Initiative Despite Gaps in Entry) trial is a single-center, pragmatic, randomized controlled trial at Vanderbilt University Hospital. It addresses the challenge of caring for hospitalized patients with opioid use disorder (OUD), who have longer hospital stays and higher readmission rates compared to other patient populations.

Patients admitted to the hospital with OUD who are being considered for medication for OUD (MOUD) in consultation with the addiction consult service are eligible. Exclusion criteria include severe psychiatric disorders requiring higher levels of care, preference for methadone maintenance, prior randomization in the study, and residence outside Middle Tennessee.

Randomization occurs via REDCap after eligibility screening by the addiction consult service social worker. The randomization ratio is 1:1, adjusted bi-weekly based on clinic capacity. Patients are randomized to either referral to the bridge clinic or usual care with community MOUD provider referrals.

The bridge clinic operates all day Friday and provides comprehensive, wraparound services including addiction psychiatry, internal medicine, infectious diseases, pain management, social work, case management, and recovery coaching. The clinic offers low-threshold, rapid access care with weekly visits for the first 8 weeks, then twice monthly, with the goal of transitioning patients to long-term care within 3 months. Services include MOUD prescribing, urine drug testing, management of co-occurring conditions, and psychosocial support. Uninsured patients receive grant-funded medications and have charges written off by the institution.

Usual care involves referrals coordinated by the primary medical team's social worker to community MOUD providers, with continuation of MOUD initiated by the addiction consult service during hospitalization.

The primary outcome is hospital length of stay. Secondary outcomes include linkage to MOUD provider, self-reported medication fills, readmission rates, emergency department visits, hospital-free and ED-free days, recurrent opioid use, quality of life (measured by Schwartz Outcome Scale-10 and EQ-5D-5L), overdose, mortality, and cost of care. For patients with infections suitable for outpatient management, additional outcomes include infection recurrence, antibiotic therapy completion, and time from negative blood culture to discharge.

Data are collected from the electronic health record and through 16-week follow-up phone calls conducted as part of routine care. Implementation measures include acceptance rates and reasons for ineligibility. The study began November 25, 2019, with anticipated completion in 18 months. Analysis will use an intent-to-treat approach with generalized linear models adjusted for covariates. The revised target sample size is 336 patients (168 per arm) based on interim review of length of stay data.",,,,DetailedDescription,protocolSection.descriptionModule.detailedDescription,True,False,True,False,False,False
Claude-4.5-Sonnet,protocolSection.conditionsModule.conditions,TP,FP,"['Opioid Use', 'Opioid-use Disorder']","['Opioid Use Disorder', 'Substance Use Disorders', 'Opioid-Related Disorders', 'Infections Related to Injection Drug Use']",False,0.0,disjoint,Condition,protocolSection.conditionsModule.conditions,False,True,True,False,False,False
Claude-4.5-Sonnet,protocolSection.conditionsModule.keywords,EV,EV,,"['Opioid Use Disorder', 'Substance Use Disorder', 'Medication for Opioid Use Disorder', 'MOUD', 'Buprenorphine', 'Naltrexone', 'Bridge Clinic', 'Transitional Care', 'Addiction Consult Service', 'Hospital Length of Stay', 'Readmission', 'Quality of Life', 'Injection Drug Use', 'Infectious Complications', 'Outpatient Parenteral Antibiotic Therapy', 'OPAT', 'Pragmatic Trial', 'Linkage to Care', 'Recovery Support']",,,,Keyword,protocolSection.conditionsModule.keywords,True,False,True,False,False,False
Claude-4.5-Sonnet,protocolSection.designModule.studyType,TP,TP,INTERVENTIONAL,INTERVENTIONAL,True,1.0,exact,StudyType,protocolSection.designModule.studyType,False,True,True,False,True,False
Claude-4.5-Sonnet,protocolSection.designModule.patientRegistry,EV,EV,,False,,,,PatientRegistry,protocolSection.designModule.patientRegistry,True,False,True,False,False,False
Claude-4.5-Sonnet,protocolSection.designModule.phases,TP,TP,['NA'],['NA'],True,1.0,exact,Phase,protocolSection.designModule.phases,False,True,True,False,True,False
Claude-4.5-Sonnet,protocolSection.designModule.designInfo.allocation,TP,TP,RANDOMIZED,RANDOMIZED,True,1.0,exact,DesignAllocation,protocolSection.designModule.designInfo.allocation,False,True,True,False,True,False
Claude-4.5-Sonnet,protocolSection.designModule.designInfo.interventionModel,TP,TP,PARALLEL,PARALLEL,True,1.0,exact,DesignInterventionModel,protocolSection.designModule.designInfo.interventionModel,False,True,True,False,True,False
Claude-4.5-Sonnet,protocolSection.designModule.designInfo.maskingInfo.masking,TP,FP,SINGLE,NONE,False,0.0,success,DesignMasking,protocolSection.designModule.designInfo.maskingInfo.masking,False,True,True,False,True,False
Claude-4.5-Sonnet,protocolSection.designModule.designInfo.maskingInfo.maskingDescription,EV,EV,,"This is an open-label pragmatic trial. All providers are aware of the trial and the randomization status of a given patient. There is no blinding of participants, care providers, investigators, or outcomes assessors.",,,,DesignMaskingDescription,protocolSection.designModule.designInfo.maskingInfo.maskingDescription,True,False,True,False,False,False
Claude-4.5-Sonnet,protocolSection.designModule.designInfo.maskingInfo.whoMasked,FN,FN,['OUTCOMES_ASSESSOR'],,False,0.0,,DesignWhoMasked,protocolSection.designModule.designInfo.maskingInfo.whoMasked,False,True,False,False,False,False
Claude-4.5-Sonnet,protocolSection.designModule.enrollmentInfo.count,TP,TP,335,336,True,0.99,success,EnrollmentCount,protocolSection.designModule.enrollmentInfo.count,False,True,True,False,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[0].measure,EV,EV,,"New, persistent, or recurrent infection",,,,OtherOutcomeMeasure,protocolSection.outcomesModule.otherOutcomes.measure,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[1].measure,EV,EV,,Completion of antibiotic therapy,,,,OtherOutcomeMeasure,protocolSection.outcomesModule.otherOutcomes.measure,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[2].measure,EV,EV,,Number of days from negative blood culture to first hospital discharge,,,,OtherOutcomeMeasure,protocolSection.outcomesModule.otherOutcomes.measure,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[3].measure,EV,EV,,Acceptance of referral to bridge clinic,,,,OtherOutcomeMeasure,protocolSection.outcomesModule.otherOutcomes.measure,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[4].measure,EV,EV,,Cross-over from usual care to bridge clinic and vice versa,,,,OtherOutcomeMeasure,protocolSection.outcomesModule.otherOutcomes.measure,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[5].measure,EV,EV,,Reasons for ineligibility,,,,OtherOutcomeMeasure,protocolSection.outcomesModule.otherOutcomes.measure,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[0].description,EV,EV,,"For patients with infection suitable for outpatient management: occurrence of new, persistent, or recurrent infection defined by a positive culture and/or change in antibiotic regimen.",,,,OtherOutcomeDescription,protocolSection.outcomesModule.otherOutcomes.description,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[1].description,EV,EV,,For patients with infection suitable for outpatient management: completion of the prescribed course of antibiotic therapy.,,,,OtherOutcomeDescription,protocolSection.outcomesModule.otherOutcomes.description,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[2].description,EV,EV,,For patients with infection suitable for outpatient management: the number of days elapsed from documentation of negative blood culture to the date of first hospital discharge.,,,,OtherOutcomeDescription,protocolSection.outcomesModule.otherOutcomes.description,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[3].description,EV,EV,,Implementation measure: the proportion of patients randomized to bridge clinic who accept the referral.,,,,OtherOutcomeDescription,protocolSection.outcomesModule.otherOutcomes.description,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[4].description,EV,EV,,Implementation measure: instances of patients switching between study arms during the follow-up period.,,,,OtherOutcomeDescription,protocolSection.outcomesModule.otherOutcomes.description,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[5].description,EV,EV,,Implementation measure: documentation of reasons why patients were not eligible for referral to the study or bridge clinic.,,,,OtherOutcomeDescription,protocolSection.outcomesModule.otherOutcomes.description,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[0].timeFrame,EV,EV,,16-week follow-up period after discharge,,,,OtherOutcomeTimeFrame,protocolSection.outcomesModule.otherOutcomes.timeFrame,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[1].timeFrame,EV,EV,,"Duration of antibiotic therapy (typically weeks), assessed within 16-week follow-up period",,,,OtherOutcomeTimeFrame,protocolSection.outcomesModule.otherOutcomes.timeFrame,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[2].timeFrame,EV,EV,,During index hospital admission,,,,OtherOutcomeTimeFrame,protocolSection.outcomesModule.otherOutcomes.timeFrame,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[3].timeFrame,EV,EV,,At time of randomization during index hospital admission,,,,OtherOutcomeTimeFrame,protocolSection.outcomesModule.otherOutcomes.timeFrame,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[4].timeFrame,EV,EV,,16-week follow-up period after discharge,,,,OtherOutcomeTimeFrame,protocolSection.outcomesModule.otherOutcomes.timeFrame,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.outcomesModule.otherOutcomes[5].timeFrame,EV,EV,,At time of screening during index hospital admission,,,,OtherOutcomeTimeFrame,protocolSection.outcomesModule.otherOutcomes.timeFrame,True,False,True,True,False,False
Claude-4.5-Sonnet,protocolSection.eligibilityModule.eligibilityCriteria,TP,TP,"Inclusion Criteria:

* Inpatients at VUH with active OUD being considered for MAT.
* Patient accepting a transitional prescription for buprenorphine-naloxone or IM naltrexone whose outpatient plans are not fixed

Exclusion Criteria:

* Deemed ineligible for referral to outpatient Bridge Clinic by the Addiction Consult Team (examples include but are not limited to patients with severe, active co-occurring psychiatric disorders requiring a higher level of psychiatric care or patients for whom methadone maintenance is deemed the best choice of MAT).
* Patients previously randomized in this study.","Inclusion Criteria:
- Aged â‰¥ 18 years
- Active OUD being considered for MOUD evidenced by accepting a transitional prescription for buprenorphine-naloxone or intramuscular naltrexone injection
- Outpatient plans not fixed prior to admission, defined as a patient reporting a prior relationship with an MOUD provider that they intend to continue after discharge, including cash pay practices
- Patient lives in one of the counties that comprise Middle Tennessee, shown in an additional file listing appropriate zip codes (see Additional file2), in order to ensure a reasonable chance of the patient having regular transportation to the clinic

Exclusion Criteria:
- Severe, active co-occurring psychiatric disorders that require a higher level of psychiatric care
- Patients for whom methadone maintenance is deemed the best choice of MOUD
- Patients previously randomized in this study
- Patients who previously were referred to the bridge clinic prior to study initiation",True,0.92,success,EligibilityCriteria,protocolSection.eligibilityModule.eligibilityCriteria,False,True,True,False,False,False
Claude-4.5-Sonnet,protocolSection.eligibilityModule.healthyVolunteers,TP,TP,False,False,True,1.0,exact,HealthyVolunteers,protocolSection.eligibilityModule.healthyVolunteers,False,True,True,False,False,False
Claude-4.5-Sonnet,protocolSection.eligibilityModule.sex,TP,TP,ALL,ALL,True,1.0,exact,Sex,protocolSection.eligibilityModule.sex,False,True,True,False,True,False
Claude-4.5-Sonnet,protocolSection.eligibilityModule.minimumAge,TP,TP,18 Years,18 Years,True,1.0,exact,MinimumAge,protocolSection.eligibilityModule.minimumAge,False,True,True,False,False,False
Claude-4.5-Sonnet,protocolSection.eligibilityModule.maximumAge,EV,EV,,N/A,,,,MaximumAge,protocolSection.eligibilityModule.maximumAge,True,False,True,False,False,False
Claude-4.5-Sonnet,protocolSection.eligibilityModule.stdAges,TP,TP,"['ADULT', 'OLDER_ADULT']","['ADULT', 'OLDER_ADULT']",True,1.0,exact,StdAge,protocolSection.eligibilityModule.stdAges,False,True,True,False,True,False
